Jupiter Life Line Hospitals Ltd (JLHL)
₹257.15
Mkt cap
₹8,527 Cr
P/E ratio
44.90
P/B
5.17
Div yield
0.08%
ROE
13.10%
ROCE
14.80%
EPS (TTM)
₹5.73
Book value
₹50
52W range
233–340
Sector
Healthcare
Price history
Previous close
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India. [1]
NSE JLHLBSE 543980
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−24.37% from high₹257
₹233+10.18% from low₹340
Current
₹257.15
Prev close
₹260.10
Day
−1.13%
Price performance
1D
+0.73%
1W
+7.38%
1M
−0.02%
3M
−21.18%
6M
+5.69%
1Y
−12.83%
YTD
−8.19%
Financials
Revenue, profit & margin
P/E ratio
44.9×
JLHL is 0% above the sector median of 44.9×
JLHL44.9×
Sector median44.9×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 263 | 273 | 291 | 289 | 335 | 333 | 337 | 353 | 394 | 365 | 388 | 411 | 456 | |
| Expenses | 202 | 211 | 228 | 223 | 257 | 256 | 257 | 275 | 301 | 282 | 299 | 332 | 350 | |
| Operating Profit | 61 | 62 | 63 | 65 | 78 | 76 | 80 | 78 | 92 | 83 | 89 | 79 | 107 | |
| OPM % | 23% | 23% | 22% | 23% | 23% | 23% | 24% | 22% | 23% | 23% | 23% | 19% | 23% | |
| Other Income | 3 | 8 | 10 | 7 | 7 | 7 | 7 | 13 | 11 | 3 | 11 | 11 | 11 | |
| Interest | 12 | 1 | 1 | 1 | 1 | 3 | 6 | 8 | 8 | 8 | 9 | 13 | 14 | |
| Depreciation | 11 | 11 | 10 | 11 | 14 | 14 | 18 | 21 | 21 | 22 | 23 | 26 | 28 | |
| Profit before tax | 41 | 58 | 62 | 60 | 70 | 67 | 63 | 62 | 74 | 57 | 68 | 51 | 75 | |
| Tax % | 19% | 25% | 27% | 26% | 26% | 22% | 28% | 29% | 23% | 25% | 26% | 26% | 25% | |
| Net Profit | 34 | 44 | 45 | 45 | 52 | 52 | 45 | 44 | 57 | 42 | 50 | 38 | 56 | |
| EPS in Rs | 1.03 | 1.33 | 1.37 | 1.36 | 1.58 | 1.59 | 1.38 | 1.34 | 1.75 | 1.30 | 1.53 | 1.14 | 1.71 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202640.91%Promoter
Promoters40.91%
FIIs9.13%0.24
DIIs19.13%2.62
Public30.85%2.35
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,200.00 | 56.05 | 1,17,903 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹638.80 | 94.90 | 84,026 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹851.15 | 55.33 | 82,843 | 0.23% | 323 | +4.87% | 2,366 | +16.70% | 14.71% |
| Aster DM Quality | ₹679.20 | 164.03 | 59,204 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹754.90 | 53.42 | 56,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,714.50 | 40.65 | 35,038 | 0.26% | 207 | +5.71% | 2,684 | +78.05% | 15.50% |
| Global Health | ₹1,299.70 | 61.04 | 34,946 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Jupiter Life Lin | ₹260.10 | 44.89 | 8,527 | 0.08% | 56 | −2.06% | 457 | +15.97% | 14.80% |
| Median: 31 Co. | ₹488.70 | 44.89 | 6,450 | 0.00% | 30 | +19.85% | 403 | +22.28% | 14.62% |
Filings
Annual reports3
Concall transcripts33
TranscriptOct 2026PPTOct 2026RECOct 2026TranscriptAug 2026PPTAug 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026PPTJan 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptMay 2025PPTMay 2025RECMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Earnings Call Transcript 29 OctAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 26 Oct - Audio link shared for Q2 and H1 FY27 analyst and investor conference call held October 26, 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 25 Oct - Intimation of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026Announcement under Regulation 30 (LODR)-Investor Presentation 23 Oct - Investor Presentation for the quarter and half year ended September 30, 2026Sale Agreement For The Acquisition Of Land 23 Oct - Board approved Q2 FY26 results, formed WOS Holitti Private Limited, and acquired Pune land for ₹150 crore.